Financial

Esperion Reports First Quarter 2020 Financial Results and Provides Company Update

Company Secures Marketing Approvals for NEXLETOL™ and NEXLIZET™ Tablets in the U.S. as well as for NILEMDO™ and NUSTENDI™ Tablets in Europe NEXLETOL™ (bempedoic acid) Tablets Commercially Available in the U.S. on March 30th  NEXLIZET™ (bempedoic acid and ezetimibe) Tablets Commercially Available in the U.S. on June 4th Strong Capital […]

Madrigal Pharmaceuticals Reports 2020 First Quarter Financial Results and Highlights

CONSHOHOCKEN, Pa., May 07, 2020 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) today announced its first quarter 2020 financial results and highlights: “Madrigal continued to make progress toward our clinical development and business objectives during the first quarter of 2020, despite challenges associated with the COVID-19 pandemic. Importantly, we continued […]

Straub Medical AG acquired by Becton, Dickinson and Company (BD)

(PresseBox) ( Wangs,04/21/20) Straub Medical AG, a privately held Swiss company, announces that it has approved a full acquisition by Becton, Dickinson and Company (BD). The acquisition was completed on April 20, 2020. Straub Medical AG is headquartered in Wangs, where it manufactures, develops and sells medical devices for the treatment of arterial […]

Stereotaxis Reports 2020 First Quarter Financial Results

ST. LOUIS, May 05, 2020 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results for the first quarter ended March 31, 2020. “Despite the challenges and disruptions inflicted by COVID-19, Stereotaxis continues to support the patients and physicians […]